Lv1
10 积分 2026-03-14 加入
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
25天前
已完结
Data from Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials
1个月前
已完结
Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease
1个月前
已完结
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
1个月前
已完结
Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study
1个月前
已关闭
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
2个月前
已完结
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
2个月前
已完结
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
2个月前
已完结
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
2个月前
已完结
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare ( GITMO ) GVHD24 Study
3个月前
已完结
皖公网安备34019202002308
